Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) - Net Assets

Latest as of September 2025: CN¥2.32 Billion CNY ≈ $340.19 Million USD

Based on the latest financial reports, Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) has net assets worth CN¥2.32 Billion CNY (≈ $340.19 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.98 Billion ≈ $436.60 Million USD) and total liabilities (CN¥658.86 Million ≈ $96.41 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Jilin Jian Yisheng Pharmaceutical Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥2.32 Billion
% of Total Assets	77.92%
Annual Growth Rate	13.5%
5-Year Change	9.44%
10-Year Change	33.72%
Growth Volatility	72.91

Jilin Jian Yisheng Pharmaceutical Co Ltd - Net Assets Trend (2006–2024)

This chart illustrates how Jilin Jian Yisheng Pharmaceutical Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 002566 total assets for the complete picture of this company's asset base.

Annual Net Assets for Jilin Jian Yisheng Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual net assets of Jilin Jian Yisheng Pharmaceutical Co Ltd from 2006 to 2024. For live valuation and market cap data, see 002566 market cap overview.

Year	Net Assets	Change
2024-12-31	CN¥2.33 Billion ≈ $341.45 Million	+0.04%
2023-12-31	CN¥2.33 Billion ≈ $341.31 Million	+3.69%
2022-12-31	CN¥2.25 Billion ≈ $329.16 Million	+2.33%
2021-12-31	CN¥2.20 Billion ≈ $321.68 Million	+3.10%
2020-12-31	CN¥2.13 Billion ≈ $312.01 Million	+3.61%
2019-12-31	CN¥2.06 Billion ≈ $301.13 Million	+4.69%
2018-12-31	CN¥1.97 Billion ≈ $287.63 Million	+3.61%
2017-12-31	CN¥1.90 Billion ≈ $277.60 Million	+5.33%
2016-12-31	CN¥1.80 Billion ≈ $263.55 Million	+3.21%
2015-12-31	CN¥1.75 Billion ≈ $255.36 Million	-0.34%
2014-12-31	CN¥1.75 Billion ≈ $256.24 Million	+4.43%
2013-12-31	CN¥1.68 Billion ≈ $245.38 Million	+5.51%
2012-12-31	CN¥1.59 Billion ≈ $232.57 Million	+4.97%
2011-12-31	CN¥1.51 Billion ≈ $221.56 Million	+321.29%
2010-12-31	CN¥359.40 Million ≈ $52.59 Million	+27.90%
2009-12-31	CN¥280.99 Million ≈ $41.12 Million	+27.79%
2008-12-31	CN¥219.89 Million ≈ $32.18 Million	+6.96%
2007-12-31	CN¥205.59 Million ≈ $30.08 Million	-13.87%
2006-12-31	CN¥238.69 Million ≈ $34.93 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Jilin Jian Yisheng Pharmaceutical Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 637.7% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	CN¥924.57 Million	41.36%
Common Stock	CN¥330.95 Million	14.80%
Other Components	CN¥980.08 Million	43.84%
Total Equity	CN¥2.24 Billion	100.00%

Jilin Jian Yisheng Pharmaceutical Co Ltd Competitors by Market Cap

The table below lists competitors of Jilin Jian Yisheng Pharmaceutical Co Ltd ranked by their market capitalization.

Company	Market Cap
Zhejiang Renzhi Co Ltd SHE:002629	$403.41 Million
The Star Entertainment Group Limited F:EE9	$403.44 Million
Enity ST:ENITY	$403.56 Million
Peijia Medical Limited F:4WO	$403.65 Million
Pharmaniaga Bhd KLSE:7081	$403.33 Million
Dave & Buster’s Entertainment NASDAQ:PLAY	$403.33 Million
Entrada Therapeutics Inc NASDAQ:TRDA	$403.21 Million
Shanghai No1 Pharmacy Co Ltd SHG:600833	$403.16 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Jilin Jian Yisheng Pharmaceutical Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 2,233,163,335 to 2,235,606,654, a change of 2,443,319 (0.1%).
Net income of 52,086,058 contributed positively to equity growth.
Dividend payments of 61,635,448 reduced retained earnings.
Other comprehensive income decreased equity by 181,095,782.
Other factors increased equity by 193,088,491.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CN¥52.09 Million	+2.33%
Dividends Paid	CN¥61.64 Million	-2.76%
Other Comprehensive Income	CN¥-181.10 Million	-8.1%
Other Changes	CN¥193.09 Million	+8.64%
Total Change	CN¥-	0.11%

Book Value vs Market Value Analysis

This analysis compares Jilin Jian Yisheng Pharmaceutical Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.23x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 8.66x to 1.23x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2006-12-31	CN¥0.96	CN¥8.33	x
2007-12-31	CN¥0.83	CN¥8.33	x
2008-12-31	CN¥0.88	CN¥8.33	x
2009-12-31	CN¥1.13	CN¥8.33	x
2010-12-31	CN¥1.45	CN¥8.33	x
2011-12-31	CN¥4.85	CN¥8.33	x
2012-12-31	CN¥4.76	CN¥8.33	x
2013-12-31	CN¥4.93	CN¥8.33	x
2014-12-31	CN¥5.21	CN¥8.33	x
2015-12-31	CN¥5.22	CN¥8.33	x
2016-12-31	CN¥5.26	CN¥8.33	x
2017-12-31	CN¥5.45	CN¥8.33	x
2018-12-31	CN¥5.61	CN¥8.33	x
2019-12-31	CN¥5.84	CN¥8.33	x
2020-12-31	CN¥6.03	CN¥8.33	x
2021-12-31	CN¥6.29	CN¥8.33	x
2022-12-31	CN¥6.51	CN¥8.33	x
2023-12-31	CN¥6.75	CN¥8.33	x
2024-12-31	CN¥6.76	CN¥8.33	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Jilin Jian Yisheng Pharmaceutical Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 2.33%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 7.79%
• Asset Turnover: 0.23x
• Equity Multiplier: 1.33x
Recent ROE (2.33%) is below the historical average (7.76%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2006	9.83%	10.37%	0.67x	1.42x	CN¥-397.47K
2007	17.63%	13.48%	0.78x	1.67x	CN¥15.63 Million
2008	18.88%	13.27%	0.90x	1.58x	CN¥19.45 Million
2009	21.81%	14.73%	0.97x	1.53x	CN¥33.10 Million
2010	24.43%	16.98%	1.00x	1.44x	CN¥51.77 Million
2011	6.46%	18.24%	0.34x	1.06x	CN¥-52.94 Million
2012	6.16%	16.09%	0.36x	1.06x	CN¥-60.26 Million
2013	5.27%	13.56%	0.34x	1.14x	CN¥-78.30 Million
2014	5.57%	12.24%	0.32x	1.44x	CN¥-76.64 Million
2015	0.63%	1.33%	0.31x	1.53x	CN¥-161.56 Million
2016	0.76%	1.41%	0.35x	1.53x	CN¥-160.89 Million
2017	3.33%	5.81%	0.39x	1.47x	CN¥-120.22 Million
2018	3.72%	7.08%	0.38x	1.38x	CN¥-116.48 Million
2019	3.96%	7.56%	0.41x	1.29x	CN¥-116.62 Million
2020	4.01%	9.50%	0.30x	1.40x	CN¥-119.51 Million
2021	4.61%	10.94%	0.31x	1.38x	CN¥-112.16 Million
2022	3.86%	10.01%	0.28x	1.38x	CN¥-132.40 Million
2023	4.24%	11.10%	0.28x	1.36x	CN¥-128.58 Million
2024	2.33%	7.79%	0.23x	1.33x	CN¥-171.47 Million

Industry Comparison

This section compares Jilin Jian Yisheng Pharmaceutical Co Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $3,235,766,232
Average return on equity (ROE) among peers: 10.99%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Jilin Jian Yisheng Pharmaceutical Co Ltd (002566)	CN¥2.32 Billion	9.83%	0.28x	$403.41 Million
Shenzhen CAU Technology Co Ltd (000004)	$120.90 Million	18.20%	3.20x	$53.47 Million
Pacific Shuanglin Bio pharmacy Co Ltd (000403)	$7.42 Billion	8.25%	0.16x	$1.66 Billion
Nanhua Bio Medicine Co Ltd (000504)	$134.48 Million	6.06%	3.14x	$443.33 Million
Jiangsu Sihuan Bioengineering Co Ltd (000518)	$833.76 Million	-21.21%	0.06x	$438.41 Million
Chengzhi Shareholding Co Ltd (000990)	$18.46 Billion	5.46%	0.32x	$2.24 Billion
Hualan Biological EngineeringInc (002007)	$2.58 Billion	14.36%	0.06x	$3.86 Billion
Da An Gene Co Ltd of Sun Yat-Sen University (002030)	$758.10 Million	18.96%	0.52x	$1.19 Billion
Shanghai RAAS Blood Products Co Ltd Class A (002252)	$831.21 Million	22.32%	0.12x	$5.40 Billion
Baolingbao Biology Co Ltd (002286)	$817.45 Million	8.24%	0.36x	$572.48 Million
Tibet Cheezheng Tibetan Medicine Co Ltd (002287)	$396.33 Million	29.23%	0.30x	$1.90 Billion

About Jilin Jian Yisheng Pharmaceutical Co Ltd

SHE:002566 China Biotechnology

Market Cap

$403.41 Million

CN¥2.76 Billion CNY

Market Cap Rank

#13642 Global

#4309 in China

Share Price

CN¥8.33

Change (1 day)

+0.48%

52-Week Range

CN¥7.07 - CN¥9.05

All Time High

CN¥19.38